14 Doctors from SBC Medical Group Receive Letters of Appreciation from Allergan Aesthetics an AbbVie Company

IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that 14 doctors affiliated with Shonan Beauty Clinic, Shonan Aesthetic Dermatology, and SBC Ochanomizu Pediatric Laser Clinic, which the Company supports, have received letters of appreciation from Allergan Aesthetics an AbbVie Company (Headquarters: Minato-ku, Tokyo; President: Tetsuo Endo), a developer, manufacturer, and distributor of products and brands leading advanced aesthetic medicine.

The letters of appreciation were presented to doctors who have contributed to the development of aesthetic medicine by playing roles such as lecturers in the company's initiatives, including the dissemination of correct knowledge and techniques regarding aesthetic medicine and educational activities for medical professionals and customers.

SBC Medical will continue to further strengthen its collaboration with advanced medical manufacturers such as Allergan Aesthetics an AbbVie Company, contributing to the sound development of the aesthetic medicine industry while pursuing the provision of optimal medical care tailored to each customer.

Doctors Received Letters of Appreciation (Alphabetical Order)

About Allergan Aesthetics an AbbVie Company

Aiming to provide innovation, education, and excellent service consistently in line with customer needs, the company develops, manufactures, and sells products and brands leading advanced aesthetic medicine in diverse fields, centering on botulinum treatment, hyaluronic acid injection treatment, partial slimming treatment by cryolipolysis, and breast reconstruction-related products.

About SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com/

For more insights and updates from SBC Holdings, follow us on LinkedIn　

Contacts

SBC Medical Group Holdings Incorporated

Murakami / PR Department E-mail: pr@sbc.or.jp